Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy

被引：32
|
作者：
Jain, Preetesh [1 ]
Nastoupil, Loretta [1 ]
Westin, Jason [1 ]
Lee, Hun Ju [1 ]
Navsaria, Lucy [1 ]
Steiner, Raphael E. [1 ]
Ahmed, Sairah [1 ]
Moghrabi, Omar [1 ]
Oriabure, Onyeka [1 ]
Chen, Wendy [1 ]
Badillo, Maria [1 ]
Flowers, Christopher R. [1 ]
Wang, Michael L. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 192卷 / 02期
关键词：
Mantle cell lymphoma (MCL); ibrutinib; brexucabtagene autoleucel; BTK inhibitor; venetoclax; chimeric antigen receptor therapy; non-Hodgkin lymphoma;
D O I：
10.1111/bjh.17197
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E38 / E42
页数：5
相关论文
共 50 条
  • [1] Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
    Chong, Elise A.
    Chong, Emeline R.
    Therwhanger, Dylan
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Barta, Stefan K.
    Svoboda, Jakub
    Gerson, James N.
    Ghilardi, Guido
    Paruzzo, Luca
    Fraietta, Joseph A.
    Weber, Elizabeth
    Stefano, Natalie
    Porter, David L.
    V. Frey, Noelle
    Garfall, Alfred L.
    Ruella, Marco
    Schuster, Stephen J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (07): : 726e1 - 726e8
  • [2] Outcomes with bendamustine lymphodepletion prior to brexucabtagene autoleucel for mantle cell lymphoma
    Chong, Elise A.
    Gerson, James N.
    Nasta, Sunita Dwivedy
    Landsburg, Daniel J.
    Barta, Stefan K.
    Svoboda, Jakub
    Weber, Elizabeth
    Chong, Emeline R.
    Schuster, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel
    Romancik, Jason T.
    Goyal, Subir
    Gerson, James N.
    Ballard, Hatcher J.
    Sawalha, Yazeed
    Bond, David A.
    Rogalski, Michael Joseph
    Greenwell, Irl Brian
    van Besien, Koen
    Yamshon, Samuel
    Karmali, Reem
    Nizamuddin, Imran
    Torka, Pallawi
    Chow, Victor A.
    Shadman, Mazyar
    Ghosh, Nilanjan
    Moyo, Tamara K.
    Fenske, Timothy S.
    Rezazadeh, Alexandra
    Grover, Natalie S.
    Maddocks, Kami J.
    Jacobson, Caron
    Cohen, Jonathon B.
    BLOOD, 2021, 138
  • [4] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [5] Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell Lymphoma
    Figura, N.
    Sim, A.
    Dahiya, S.
    Lutfi, F.
    Rapoport, A.
    Mohindra, P.
    Dohm, A.
    Chavez, J.
    Shah, B.
    Khimani, F.
    Lazaryan, A.
    Davila, M.
    Bachmeier, C.
    Nishihori, T.
    Liu, H.
    Kim, S.
    Locke, F.
    Jain, M.
    Robinson, T.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S894 - S895
  • [6] Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom
    O'Reilly, Maeve A.
    Sanderson, Robin
    Wilson, William
    Burns, David
    Besley, Caroline
    Creasey, Thomas
    Uttenthal, Ben
    Elliot, Johnathon
    Roddie, Claire
    Kuhnl, Andrea
    Paneesha, Shankara
    Seymour, Frances
    Iyengar, Sunil
    Rubio, Lourdes
    Wilson, Matthew
    Boyle, Stephen
    Cheok, Kathleen Pl
    Collins, Graham P.
    Johnson, Rod
    McMillan, Andrew K.
    BLOOD, 2022, 140 : 7519 - 7521
  • [7] Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma
    Marchetti, M.
    Visco, C.
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1442 - 1450
  • [8] Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
    Aydilek, Enver
    Klein-Scory, Susanne
    Thomson, Julia
    Nilius-Eliliwi, Verena
    Vangala, Deepak
    Schroers, Roland
    Wulf, Gerald
    Mika, Thomas
    HEMASPHERE, 2023, 7 (09):
  • [9] Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma
    Fetooh, A.
    Lionel, A.
    Fang, P.
    Nze, C. C.
    Ahmed, S.
    Westin, J.
    Flowers, C.
    Pinnix, C. C.
    Dabaja, B.
    Gunther, J. R.
    Neelapu, S. S.
    Wang, M. L.
    Jain, P.
    Wu, S. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E622 - E623
  • [10] Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis
    Khurana, Arushi
    Dalland, Joanna C.
    Young, Jason R.
    Inwards, David J.
    Paludo, Jonas
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : E298 - E301
12345